Login / Signup

Aggressive prolactinomas responsive to temozolomide treatment: Report of two cases.

Zahra DavoudiMohammad HallajnejadElena JamaliMohammadjavad Honarvar
Published in: Clinical case reports (2022)
Refractory aggressive prolactinomas are detected after the unresponsiveness to conventional therapies. We report two cases that underwent temozolomide treatment and have been in near-complete remission ever since. We suggest the pathology techniques for earlier detection and, subsequently, treatment with temozolomide to reduce morbidities and better respond to therapy.
Keyphrases
  • stem cells
  • rheumatoid arthritis
  • systemic lupus erythematosus
  • drug delivery
  • replacement therapy
  • disease activity
  • quantum dots
  • label free